Deccan Healthcare Appoints Independent Directors, Updates Leadership Team

Deccan Health Care Limited has announced significant changes to its board composition and leadership structure. The company held a board meeting on December 11, 2025, resulting in key appointments and organizational updates.

Board Appointments

The board has approved the appointment of two new Independent Directors based on recommendations from the Nomination and Remuneration Committee:

Director Details:	Samhitha Kandalkunta	Karishma D. Patel
Position:	Non-Executive Independent Director	Non-Executive Independent Director
Effective Date:	December 11, 2025	December 11, 2025
Term Duration:	5 years	1 year
Approval Status:	Subject to member approval	Subject to member approval

Samhitha Kandalkunta - Reappointment

Samhitha Kandalkunta, who previously served as an Independent Director, has been reappointed to the board. Her qualifications include an MBA in Finance and a PG Diploma in Alternative Dispute Resolution from NALSAR University of Law and ICADR, India. She has also completed a Masters in Law of Financial Services and Capital Markets, bringing over 8 years of working experience in the field.

Karishma D. Patel - New Appointment

Karishma D. Patel joins the board with strong technical credentials, holding an M.Sc. in Information Technology and a B.C.A. She brings over a decade of experience in software development, database management, and IT administration. Her technical expertise spans ASP.NET, Core Java, HTML, SQL Server, Oracle, and associated tools, with hands-on experience in developing systems such as ERP and Recruitment Processing Systems.

Leadership Transition Updates

The company has provided updates on its earlier announced leadership changes:

Leadership Change:	Details
Outgoing Officer:	Ronak Darji (Company Secretary & Compliance Officer)
Resignation Date:	December 1, 2025 (post office hours)
Notice Period:	Resigned without serving prescribed notice period
Interim Arrangement:	Mohita Gupta designated as Interim Compliance Officer
Future Plans:	New Company Secretary to be appointed in compliance with law

The company is currently awaiting formal handover of charges and records from the outgoing officer. Mohita Gupta has been authorized to discharge compliance-related responsibilities until a new Company Secretary is appointed.

Financial Position

Based on the most recent balance sheet data, the company shows steady growth:

Financial Metric:	Current Year (2025-03)	Previous Year (2024-03)	Change (%)
Total Assets:	₹123.90 crore	₹107.30 crore	+15.47%
Current Assets:	₹105.20 crore	₹87.50 crore	+20.23%
Total Equity:	₹106.60 crore	₹97.00 crore	+9.90%
Current Liabilities:	₹14.50 crore	₹7.10 crore	+104.23%

The board meeting, conducted through video conferencing, commenced at 5:00 PM and concluded at 5:20 PM on December 11, 2025. These appointments are subject to approval by members at the ensuing general meeting, and both directors are liable for retirement by rotation as per company regulations.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+2.32%	-2.09%	-9.12%	-18.51%	-48.89%	-55.41%

Deccan Health Care has reported strong financial performance for the second quarter, demonstrating significant growth in both revenue and profitability.

Financial Highlights

Metric	Q2 FY2025-26	YoY Growth
Revenue	₹2,440.46 lakh	29.7%
Net Profit	₹89.97 lakh	67.5%
EBITDA Margin	7.0%	Up from 3.4%

The company's standalone revenue for Q2 reached ₹2,440.46 lakh, marking a substantial 29.7% increase year-over-year. This growth was primarily driven by product diversification and digital expansion strategies. The net profit for the quarter stood at ₹89.97 lakh, representing a remarkable 67.5% surge compared to the same period last year.

Improved Profitability

Deccan Health Care has significantly enhanced its profitability, with the EBITDA margin improving to 7.0% from 3.4% in the previous year. This improvement reflects the company's focus on operational efficiency and cost management.

Half-Year Performance

For the first half of FY2025-26, Deccan Health Care reported:

Standalone revenue of ₹4,587.41 lakh, up 35.4% YoY
Half-yearly PAT of ₹111.22 lakh, an increase of 22.8% YoY

Strategic Initiatives

The company has broadened its wellness portfolio with innovative product launches, including:

EnergyDecc™
SlimDecc™
Reactive Go Advanced
New range of functional fruit bars and gummies

Deccan Health Care has also introduced a Weight Wellness Program, focusing on metabolic balance, vitality, and holistic well-being through three synergistic formulations.

Global Expansion

The company is actively pursuing international growth:

Regulatory approvals filed in 6 international markets
Product launches in UAE and GCC planned for March 2026

Management Commentary

Mr. Mohak from Deccan Health Care stated, "Our Q2 performance demonstrates the resilience of our model and rising consumer preference for preventive, scientific wellness. We remain focused on disciplined execution, export-readiness, and sustained long-term value creation."

Outlook

With its strong financial performance, product innovation, and international expansion plans, Deccan Health Care appears well-positioned for continued growth in the preventive healthcare and wellness sector. The company's focus on science-backed formulations and strategic market expansion may contribute to its future success in both domestic and international markets.

Investors and stakeholders will likely keep a close eye on Deccan Health Care's ability to maintain this growth trajectory and successfully execute its expansion plans in the coming quarters.